A Cell Line that Expresses secNluc and GFP to Recapitulate PMP22 Gene Expression for Studying Peripheral Neuropathy

Description:
This technology includes a cell line that expresses two reporters (a secreted luciferase, secNLuc, and GFP) in a pattern that recapitulates the endogenous expression of the peripheral myelin protein 22 (Pmp22) gene. Pmp22 is mainly expressed in the Schwann cells of the peripheral nervous system. Many neurological disorders are associated with aberrations in Schwann cells, including the most common inherited peripheral neuropathy known as Charcot-Marie-Tooth (CMT) disease. This cell line will permit the study of the regulatory elements behind the gene.
Patent Information:
For Information, Contact:
Suryanarayana Vepa
Technology Licensing Specialist
NIH Technology Transfer
301-827-7181
sury.vepa@nih.gov
Inventors:
John Svaren
Sung-Wook Jang
James Inglese
Keywords:
Cell
Coincidence
ENDOGENOUS
ENGINEERED
Express
Expression
Gene
GENETICALLY
GFP
Line
Listed LPM Tong as of 4/15/2015
LOCUS
Pmp22
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
Recapitulate
Reporters
SecNluc
That
VEXXXX
WIXXXX
XEXXXX
© 2024. All Rights Reserved. Powered by Inteum